News from biodelivery sciences international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 10, 2014, 08:00 ET
BDSI Logo.

BioDelivery Sciences Launches InReach Support Program for Those Affected by Opioid Dependence

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI), who recently launched BUNAVAIL® (buprenorphine and naloxone) buccal film...

Dec 08, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed the randomization of all patients in BDSI's ongoing initial...

Nov 25, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences to Present at the 26th Annual Piper Jaffray Healthcare Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Nov 13, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences to Present at the Stifel 2014 Healthcare Conference and the Jefferies 2014 Global Healthcare Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Nov 07, 2014, 10:34 ET
BDSI Logo.

BioDelivery Sciences to Present at the Credit Suisse 2014 Healthcare Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Nov 05, 2014, 17:19 ET
BDSI Logo.

BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Third Quarter 2014 Financials

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended...

Nov 03, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences Announces the Availability of BUNAVAIL™ in the U.S.

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) is...

Oct 28, 2014, 08:00 ET
BDSI Logo.

BioDelivery Sciences to Develop a Long-Acting Injectable Depot Formulation of Buprenorphine with Evonik for Use in Opioid Dependence and Pain

 BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) has entered into an exclusive agreement with Evonik Corporation to develop and...

Oct 10, 2014, 11:15 ET

BioDelivery Sciences Announces the Hiring of J. Chris Prue as Vice President of Regulatory Affairs and Quality Assurance

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that J. Chris Prue, RPh, MBA has joined BDSI as Vice President of...

Oct 06, 2014, 19:49 ET

BioDelivery Sciences to Provide BUNAVAIL Launch Update

 BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) will host an investor update conference call and webcast to discuss the...

Sep 08, 2014, 07:00 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences to Present at the Morgan Stanley Global Healthcare Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Sep 03, 2014, 07:00 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences to Ring The NASDAQ Stock Market Opening Bell

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the company will visit the NASDAQ MarketSite in Times Square on...

Aug 27, 2014, 08:00 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences to Host Investor and Analyst Event and Webcast Friday, September 5 on BUNAVAIL™ Launch and Pipeline

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the company will be hosting an investor and analyst event and simultaneous...

Aug 12, 2014, 07:00 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that along with its commercial partner, Endo Pharmaceuticals, engaged in a...

Aug 07, 2014, 16:45 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2014 Financials

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended...

Aug 06, 2014, 07:00 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that it has completed a pre-specified interim analysis of the ongoing...

Jul 22, 2014, 08:00 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that its Board of Directors has appointed Charles J. (Chuck) Bramlage and...

Jun 26, 2014, 07:00 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences Announces Completion of Patient Enrollment in its Initial Phase 3 Trial of Clonidine Topical Gel for Painful Diabetic Neuropathy

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed enrollment of all patients required for its initial...

Jun 11, 2014, 11:34 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences Featured on Bloomberg TV, TheStreet.com and Business News Network

 Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) was interviewed on...

Jun 10, 2014, 07:00 ET
BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

BioDelivery Sciences to Present at the William Blair and Wells Fargo Healthcare Conferences

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...